Table 3 ANOVA and pearson test results for serum indicators stratified by BMI categories and gender.
From: Metabolic and hepatic biomarkers associated with MASLD in the Chinese population
Groups | Male | Female | |||||
|---|---|---|---|---|---|---|---|
Normal BMI | Overweight | Obesity | Normal BMI | Overweight | Obesity | ||
ALT | Pearson r | 0.013 | -0.012 | -0.039 | 0.016 | -0.005 | -0.004 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
AST | Pearson r | -0.012 | -0.011 | -0.032 | 0.044 | -0.002 | -0.003 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
AST/ALT | Pearson r | 0.023 | 0.018 | -0.021 | 0.004 | -0.009 | -0.002 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
FBG | Pearson r | 0.022 | -0.016 | -0.010 | 0.030 | -0.034 | -0.036 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
SBP | Pearson r | 0.011 | 0.015 | -0.002 | 0.016 | 0.010 | -0.051 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
DBP | Pearson r | 0.002 | 0.011 | 0.023 | 0.002 | 0.009 | -0.031 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
TC | Pearson r | 0.029 | 0.065 | -0.008 | -0.094 | -0.044 | -0.030 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
TG | Pearson r | 0.015 | -0.018 | 0.050 | -0.001 | -0.005 | -0.003 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
HDL-C | Pearson r | 0.022 | -0.014 | 0.002 | 0.002 | -0.016 | 0.029 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |
LDL-C | Pearson r | 0.020 | 0.009 | 0.040 | -0.047 | 0.030 | -0.014 |
ANOVA | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | P < 0.001 | |